OneMedNet Welcomes New Subscriber mlHealth360, Expanding Subscription-Based Business Model

OneMedNet Corporation, a leader in AI-powered Real-World Data, has announced that mlHealth360, a healthcare AI and analytics innovator, has chosen OneMedNet as its Real-World Data provider. The multi-year agreement will provide mlHealth360 with continuous access to regulatory-grade, de-identified imaging and clinical data for AI model development, validation, and deployment. This partnership strengthens OneMedNet's growing base of subscription customers and reinforces the trust and confidence organizations place in their ability to deliver high-quality medical imaging data.

OneMedNet Corporation (NASDAQ: ONMD), a leading provider of AI-powered Real-World Data (RWD), has announced a significant milestone in its growth trajectory. On October 20, 2025, the company welcomed mlHealth360 as a new subscriber to its iRWD™ platform, securing a multi-year subscription for regulatory-grade, de-identified imaging and clinical data. This deal marks a substantial expansion for OneMedNet, further cementing its position in the healthcare AI and analytics sector.

The partnership with mlHealth360 will provide continuous access to curated X-ray and CT datasets sourced from over 1,750 healthcare provider sites and 131 million+ clinical studies. This data will support the development, validation, and deployment of AI models, aligning with OneMedNet's subscription-based strategy to build annual recurring revenue. The deal underscores the growing demand for high-quality medical imaging data in the AI and analytics space.

The agreement is a strategic move for OneMedNet, which has been facing challenges in scaling its business and maintaining profitability. The company's revenue growth has been robust, with iRWD revenues growing at a significant rate, albeit from a small base. The partnership with mlHealth360 is expected to provide a steady stream of recurring revenue, which is crucial for the company's financial sustainability.

However, the company's financial health remains a concern. OneMedNet has been operating at a loss, with significant expenses allocated to General and Administrative (G&A) costs. The company's reliance on equity financing has led to substantial dilution, raising questions about its long-term financial viability. Despite these challenges, the subscription deal with mlHealth360 is a positive step forward, indicating that OneMedNet's data offerings are gaining traction in the market.

The future of OneMedNet will depend on its ability to maintain data quality, compliance, and customer retention. The company will need to continue expanding its customer base and demonstrating the value of its data offerings to achieve sustainable growth.